Novo Nordisk increases transparency on tax payments
Due to a shift in Novo Nordisk's tax reporting policy, the firm will prospectively be more transparent about its global tax payments, states head of tax Camilla Wright.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Danish pharmaceutical company Novo Nordisk is increasing its transparency on company tax payments, and in the future it will report on more detailed information from single markets in which the firm operates, according to Danish financial media Økonomisk Ugebrev.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
